Rare diseases
Investigational molecules
Locations
703 conditions with trials, the busiest first
3 898 trials across Europe, recruiting first
Study of WEF-001 safety and effectiveness in patients with advanced KRAS-mutant solid tumors
SpainStudy of gilteritinib with fludarabine, cytarabine and idarubicin combination therapy in newly diagnosed FLT3-positive acute myeloid leukemia patients
ItalyLong-term follow-up study of fianlimab and cemiplimab combination treatment in adult patients with melanoma
IrelandStudy of TORL-1-23 and pegfilgrastim in women with advanced platinum-resistant ovarian, peritoneal, or fallopian tube cancer expressing CLDN6
AustriaComparing two treatment regimens with drug combination for newly diagnosed low-risk medulloblastoma to evaluate cognitive function outcomes
BelgiumStudy of Sacituzumab Govitecan and Zimberelimab for Muscle-Invasive Bladder Cancer in Patients Unable to Take Cisplatin or Unwilling to Have Surgery
ItalyStudy of oral TherO2-01S22 with anti-HER2 therapy in patients with metastatic breast cancer
FranceStudy on the Effects of Different Dosing Schedules of Irinotecan Hydrochloride, Calcium Folinate, and Fluorouracil in Patients with Metastatic Colorectal Cancer
HungaryStudy to Examine Distribution of Aromatase Inhibitor and Ribociclib in ER+ HER2- Early Breast Cancer in Postmenopausal Women Scheduled for Surgery
The NetherlandsEvaluation of Datopotamab Deruxtecan in Patients with Non-Squamous Non-Small Cell Lung Cancer and Active Brain Metastases
AustriaEvaluating Technetium-99m and Cyanine-5 PSMA Tracer-Guided Surgery for Patients with Prostate Cancer
The NetherlandsStudy of Valemetostat Tosylate with Drug Combination for Patients with Previously Treated Solid Tumors
FranceThe therapies tested most often in Neoplasms benign, malignant and unspecified (incl cysts and polyps) trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
